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Strengths and limitations of this study
 ► Scoping review categorising and summarising a 
wide range of apps available for cancer survivors 
on on-line stores.
 ► Content and thematic analysis based on verbatim 
descriptions from the stores.
 ► Individual apps not downloaded or quality assessed.
AbStrACt
Objectives To review the nature and scope of apps 
targeting individuals living with and beyond cancer.
Design Scoping review, searching the two largest app 
stores, Google Play and Apple’s App store. App descriptions 
were exported verbatim, and summarised descriptively, 
thematically and by content coding.
results We included 151 apps targeting individuals 
living with and beyond cancer. Most targeted all cancer 
types (n=89, 58.9%) or breast cancer (n=22, 14.6%) 
and originated in the USA (n=68, 45.0%). The country of 
origin was unclear for 31 (20.5%) apps. Most apps were 
developed by commercial companies/private individuals 
(n=64, 43%) or non-profit organisations (n=30, 19.9%) 
and marketed apps in terms of fighting metaphors, 
navigating a journey and becoming empowered to take 
control.
App content could be summarised under five main 
categories: (1) imparting information about cancer; (2) 
planning and organising cancer care; (3) interacting with 
others (including others affected by cancer and healthcare 
professionals); (4) enacting management strategies and 
adjusting to life with or beyond cancer and (5) getting 
feedback about cancer management, for example, by 
sharing self-monitoring reports with professionals. We 
found some apps describing ‘cures’ for cancer or selling 
products, such as alkaline waters to cancer survivors.
Conclusions Apps are currently available via on-
line stores that cover a large spectrum of cancer 
survivorship activities. The effects of such apps on clinical 
consultations, patient work/burden and clinical outcomes 
merit further attention. Most apps are developed by 
commercial organisations, and promises of empowerment 
in the ‘fight’ against cancer are tempered by the potential 
for exaggerated claims and exploitation.
IntrODuCtIOn
The number of individuals living with and 
beyond cancer (also known as cancer survi-
vors) is increasing.1 2 In the UK, it is estimated 
that the number of cancer survivors will grow 
by approximately one million every decade, 
from 2.1 million in 2010 to 5.3 million in 2040.2 
Cancer is increasingly being regarded as a 
chronic disease due to the growing number 
of individuals who are living with cancer 
or surviving cancer3 with long-term symp-
toms4 and late effects of cancer treatment.5 
Cancer survivors can experience increased 
physical, psychological and social issues after 
their diagnosis,6 accompanied by a range 
of unmet needs.7 There is growing political 
and clinical interest in using digital technolo-
gies to deliver efficient, high-quality care for 
cancer survivors8 and to empower patients to 
perform self-management activities.9
The market for apps, including health apps, 
is growing rapidly,10 11 with an estimated 318 
000 health apps available in 2017.12 It is esti-
mated that over 200 health apps are added 
daily to app stores.13 Against this changing 
technological environment, attempts to 
summarise and evaluate healthcare apps in 
traditional systematic reviews are limited by 
the relatively small proportion of technolo-
gies, which are reported in published litera-
ture.14 15 An alternative strategy has been to 
identify and review apps that are available for 
download via on-line stores.16–18
In 2012, Bender et al searched on-line stores 
to characterise the purpose and content of 
apps focusing on any aspect of cancer.19 Of 
295 cancer apps, most were limited in their 
scope, focusing primarily on providing infor-
mation and raising awareness about cancer 
in general and promoting/fundraising for 
charities.19 In 2014, Kassianos et al searched 
on-line stores for melanoma detection apps, 
identifying 39 apps. Most gave education 
or advice about melanoma, ultraviolet radi-
ation exposure and skin self-examination 
strategies.20
Relatively, little is known about apps 
targeting people living with and beyond 
cancer. Dahlke et al21 conducted a review 
to identify behaviour change techniques 
(BCTs)22 embedded in cancer survivorship 
apps, searching app stores in November 
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2013.21 Eighteen BCTs were present across 65 apps, 
including providing instruction, tailoring (e.g. adjusting 
the information delivered based on user input), personal-
isation (e.g. the user can select elements specific to them 
such as disease type) and prompting intention formation. 
What was less clear were the range of behaviours targeted, 
the aims and scope of the apps, how the BCTs were opera-
tionalised and organised, and where the technology itself 
might add value to survivorship care.
The aim of this review is to characterise apps targeting 
individuals living with and beyond cancer that are 
currently available for download via the two major app 
stores (Google Play and Apple’s App Store), which have 
been estimated to contain over 90% of all apps.20 The 
review will provide a summary of the apps’ advertised 
components, stated aims and technological features. We 
aim to categorise and organise the apps such that clini-
cians, app developers and policy-makers can make sense 
of the current international app market for people living 
with and beyond cancer.
MethODS
We performed a scoping review,23 searching Apple’s App 
Store and Google Play to identify apps targeting people 
living with and beyond cancer, and used content anal-
ysis24 to characterise advertised content. Scoping reviews 
differ from traditional systematic reviews in that they 
map a topic in order to communicate the breadth and 
depth of the field,25 and do not tend to involve formal 
quality assessment of the evidence.23 They describe the 
‘extent, range and nature’23 of the available evidence, 
and set it in context in terms of current understanding. 
Scoping reviews require analytical interpretation of the 
subject area.26 They are particularly useful when synthesis 
involves non-research material,26 and for emerging areas 
of research.
In this scoping review, we did not download and interact 
with the apps or test quality or functionality. In a previous 
review, Kassianos et al used app store summaries and 
were able to yield detailed descriptions of melanoma app 
content.20 Based on older reviews,19 21 we expected to find 
a large number of apps, and in this rapidly changing field, 
the time required to interact with each app would lead 
to significant delays in communicating our findings. We 
wished to include paid apps, and had limited resources to 
buy individual apps for multiple authors. We also wished 
to include any apps affiliated with specific centres or clin-
ical trials which would require log in credentials.
Search strategy
Initial searches were conducted by two authors, DM and 
RA, who refined the search criteria. The lead author then 
searched the two leading app stores, Apple’s App store 
(we used an iPhone with iOS operating system), and 
Android’s Google Play (we used a Personal Computer 
(PC) with Windows operating system) in September 2018 
using the keywords ‘cancer’, ‘cancer survivor’ and ‘cancer 
survivorship’.
Inclusion and exclusion criteria
We included: apps aimed at patients living with and 
beyond cancer; free and paid apps from any country; 
apps that included prediagnosis support and information 
(so long as they also specifically targeted individuals living 
with and beyond cancer); and apps covering more than 
one clinical condition, so long as cancer was a named 
condition.
We excluded: apps unavailable in English or without 
English descriptions; simple awareness raising or predi-
agnosis apps (apps raising awareness of symptoms that 
were potentially indicative of cancer or risk assessment 
tools, skin/mole checking apps for individuals without a 
diagnosis of skin cancer, simple factsheets about a certain 
cancer type or glossaries); and recipe and diet apps that 
were not specifically targeting patients living with and 
beyond cancer.
Apple’s App store operates a ‘continuous scroll’ func-
tion, meaning that the store loads content continuously 
to return results. General search terms or keywords (eg, 
‘cancer’) can result in ‘endless scrolling’ or ‘infinite 
scrolling’, where results are continuously returned without 
an apparent endpoint. Our initial scoping searches 
showed that apps became much less relevant after the first 
few hundred results, and we decided to limit our search 
of Apple’s App store to the first 500 results for the term 
‘cancer’. The on-line stores are not set up to allow search 
results to be exported, and decisions about inclusion and 
exclusion were made by a single author (RA). Eligibility 
was determined from the descriptions of the apps within 
the app stores. Descriptions of the final apps selected 
for inclusion were reviewed by a second author (DM) to 
ensure that apps met the eligibility criteria.
Data extraction and synthesis
A data extraction form was created in Microsoft Excel and 
two researchers (RA and DM) independently extracted 
data from all apps that met the inclusion criteria. Data 
were obtained from the stores’ on-line app descriptions, 
principally the narrative text, but notes were also taken 
based on screenshots of the apps within the store. These 
notes were added to summarise any visible content from 
the screenshots which was in image form but not directly 
mentioned in the app description. Verbatim text from the 
screenshots was imported where available. We searched 
for and visited developer websites when available in order 
to gather background information on the app, partic-
ularly with respect to the nature of the organisation 
involved in app development (eg, non-profit organisation 
or charity, commercial, academic) and country of origin.
Data were extracted on: cancer type(s); name of owner 
and/or developer (sometimes the same); country of 
origin; operating system (Apple/Android/both); fee to 
download; type of owner (charity, commercial, academic 
institution, healthcare provider and combination); 
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number of downloads (available on Google Play only); 
star rating and the presence/absence of a statement 
about clinical or scientific input into app development. 
Data on number of downloads, and star ratings were 
extracted by the lead author alone, as this was judged to 
be a changing parameter. Data were imported into SPSS 
V.24, and descriptive statistics were calculated.
The text description of the app given in the on-line store 
was copied verbatim and imported into Microsoft Word. 
We used content analysis24 and thematic analysis27 to 
organise, categorise and synthesise qualitative data. App 
descriptions and accompanying notes were imported into 
NVivo V.11. Data familiarisation took place by reading 
and rereading app descriptions. Initial codes were gener-
ated by the lead author in order to organise the data 
into meaningful groups and these were discussed with a 
second author (DP).28 Codes were sorted into categories, 
based on how the codes were related and linked. Each 
app was then analysed independently by two reviewers 
(RA and DM) to categorise the advertised content. The 
reviewers were alert to any content which did not fit the 
categories. We also analysed themes within the language 
used to describe the apps. Reviewers met after the data 
categorisation exercise and compared results, reaching 
consensus by discussion.
Patient and public involvement
We did not involve patients or the public in this scoping 
review, but rather plan to use the results to inform tech-
nology codesign projects which involve patients and the 
public.
reSultS
We screened 1265 apps and included 151 in our final 
synthesis (see flow chart, figure 1). The main reasons for 
exclusion were apps not specifically targeting cancer survi-
vors, only targeting clinicians or not relating to cancer. 
Four apps (Cancer Stage IV Cure Methodology, Driver, Inspire 
and NIH Breast Cancer Information) became unavailable 
during our data analysis process between 8 September 
2018 and 24 May 2019, and were excluded because we 
were unable to return to the on-line descriptions to check 
accuracy during dual data extraction.
A full list of included apps, data on star ratings and the 
raw data used in our analyses are included in the online 
supplementary file 1. App names will be reported in 
Italics throughout our results.
App demographics
Characteristics of the apps are provided in table 1. Of 
note, most of the apps covered all cancer types (n=89, 
58.9%) or were specific to breast cancer (n=22, 14.6%). 
Over 90% were free to download. Apps were developed 
by a mix of private companies/individuals (n=64, 43%), 
charity/non-profit organisations (n=30, 19.9%), health-
care organisations (n=15, 9.9%) and academic institutions 
(n=8, 5.3%). We found apps sharing the same developer 
and with similar content, but differing by cancer type: 
Eight apps were developed by ‘@point of care’, and five 
apps developed by ‘Self-care catalysts’, both commercial 
developers based in the USA. The nature of the devel-
oper could not be determined for 16 apps (10.6%).
Unlike Apple’s App store, Google Play provides statis-
tics for the number of app downloads. Of the 104 apps 
available on Google Play, 45 apps (43.3%) had been 
downloaded less than 100 times. Five apps ( Cancer. net 
mobile, MD Anderson mobile, Cancer fighting food, Cancer 
Curing foods and My Cancer Coach) had between 10 000 and 
50 000 downloads. One app, Belong Life, had over 50 000 
downloads. Belong Life markets itself as an ‘information 
sharing platform’, featuring an on-line social network 
of individuals with cancer, healthcare professionals who 
answer questions, access to personalised information and 
a clinical trial matching service.
themes within on-line descriptions of the apps
Verbatim app descriptions and text from screenshots ran 
to over 30 000 words. Three prominent themes were: 
Fighting for Life, Navigating a Journey and Being Empow-
ered to Take Control. Examples of app descriptions fitting 
these themes, with quotations, are included in table 2. 
Fighting metaphors were observed within a range of apps 
and were sometimes contained within the app title (eg, 
Attack Cancer using Hypnosis & Guided Imagery/Meditation, 
Cancer Defeated and Cancer Fighting Foods). In fighting 
metaphors, cancer was depicted as an enemy invader and 
surviving cancer as a battle. Metaphors about fighting and 
battles were prominent in apps promoting healthy eating 
or specific ‘cancer-fighting’ foods or diets.
Cancer was often compared with a journey and apps 
marketed themselves as tools to help navigate that 
journey. Apps that incorporated social networking often 
emphasised that the cancer journey did not have to be 
navigated alone. Social networking was suggested as a 
source of knowledge and emotional support. Many apps 
promoted peer comparison, and emphasised that others 
around the world were facing very similar problems, with 
some apps referring to ‘others like you’. There was a sense 
within language used that cancer was associated with loss 
of control, and that downloading and interacting with 
an app was a method of empowerment and taking back 
control. Apps were marketed to individuals as a method 
of becoming actively involved in self-management.
Content analysis
The apps offered content that could be summarised 
under five main categories: (1) imparting information 
about cancer; (2) planning and organising cancer care; 
(3) interacting with others (including others affected 
by cancer and healthcare professionals); (4) enacting 
management strategies and adjusting to life with or 
beyond cancer and (5) getting feedback about cancer 
management. The specific app features that support each 
of these activities are summarised in table 3 and discussed 
below.
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Figure 1 Identification and screening process for apps included in this review.
Imparting information about cancer
Over half the apps (n=81, 53.6%) stated in their descrip-
tion that they provided information or educational mate-
rials about cancer; for example, the nature of cancer, 
aspects of terminology related to cancer and cancer treat-
ments. The apps presented this in various ways, including 
fact-sheets/written information, news feeds and updates, 
questions and answers, and videos. Some apps (eg, Breast 
Cancer Ally) provided personalised information based 
on user-reported characteristics, including treatments 
received or disease subtype. One app, Personalized Sarcoma 
Care, offered prognostic information to users with high-
grade soft-tissue sarcoma of the limb who were going to 
be treated with surgery and radiotherapy. The app offered 
a disclaimer that it was not a medical device, not meant 
to be used to inform clinical decisions, and not tested for 
clinical usefulness. Users were instructed to discuss prog-
nostic results with their physician.
Planning and organising cancer care
Twenty-five apps (16.6%) allowed users to enter and store 
records relating to their cancer care, such as results or 
diaries of treatments they had received. Apps also allowed 
users to keep a calendar of appointments (n=12, 8.0%) 
and to keep lists and scheduling of medications (n=20, 
13.3%). Three apps (MD Andersen Mobile, MyMSK and 
NED) allowed registered users linked to the specific 
cancer centre to log in and view some of their own results. 
Four apps (MD Andersen Mobile, MyMSK, CanHOPE cancer 
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Table 1 Description of apps targeting individuals living with and beyond cancer available on Apple’s App Store and Google 
Play
Cancer types covered
No (N) (all apps, 
n=151 n (%)
Unique to Apple
n=47,
N (%)
Unique to 
Google n=38
N (%)
All cancers 89 (58.9) 23 (48.9) 24 (63.2)
Breast 22 (14.6) 9 (19.1) 5 (13.2)
Prostate 9 (6.0) 5 (10.6) 2 (5.3)
Lung or mesothelioma 5 (3.3) 2 (4.3) 2 (5.2)
Bladder or renal 5 (3.3) 3 (6.4) 1 (2.6)
Liver and/or pancreas 3 (2.0) 3 (6.4) 0 (0.0)
Haematological 3 (2.0) 0 (0.0) 1 (2.6)
Retinoblastoma, eye or childhood cancers 3 (2.0) 0 (0.0) 1 (2.6)
Colorectal 2 (1.3) 0 (0.0) 0 (0.0)
Melanoma 2 (1.3) 1 (2.1) 0 (0.0)
Multiple cancers (breast and ovarian, breast, prostate and 
colorectal)
2 (1.3) 0 (0.0) 0 (0.0)
Head and neck or oral 2 (1.3) 1 (2.1) 1 (2.6)
Others (testicular, ovarian, soft-tissue sarcoma, carcinoid) 4 (2.6) 0 (0.0) 1 (2.6)
Type of developer
  Commercial or private organisation 65 (43.0) 23 (48.9) 20 (52.6)
  Charity or non-profit organisation 30 (19.9) 12 (25.5) 1 (2.6)
  Unclear 16 (10.6) 2 (4.3) 11 (28.9)
  Healthcare organisation 15 (9.9) 7 (14.9) 3 (7.9)
  Academic organisation 8 (5.3) 2 (4.3) 2 (5.3)
  Clinical or research societies/networks or government 4 (2.7) 0 (0.0) 0 (0.0)
  Partnership of various types of organisation 13 (8.6) 1 (2.1) 1 (2.6)
Country of origin
  USA 68 (45.0) 25 (53.2) 5 (13.2)
  Unclear 31 (20.5) 7 (14.9) 17 (44.8)
  UK, Ireland or Gibraltar 15 (9.9) 8 (17.0) 1 (2.6)
  Multinational 7 (4.6) 2 (4.3) 1 (2.6)
  India 7 (4.6) 0 (0.0) 5 (13.2)
  Canada 5 (3.3) 0 (0.0) 2 (5.3)
  Malaysia or Singapore 5 (3.3) 1 (2.1) 3 (7.9)
  Australia 4 (2.6) 2 (4.3) 0 (0.0)
  The Netherlands 3 (2.0) 1 (2.1) 1 (2.6)
  Others (France, Germany, Hungary, Morocco, Pacific 
Islands, Spain)
6 (4.0) 1 (2.1) 3 (7.9)
No of downloads (Google Play data only for 104 apps)
  <100 45 (43.3) 17 (44.7)
  100–500 24 (23.1) 10 (26.3)
  500–1000 9 (8.7) 4 (10.5)
  1000–5000 17 (16.3) 4 (10.5)
  5000–10 000 3 (2.9) 1 (2.6)
  10 000–50 000 5 (4.9) 2 (5.3)
  >50 000 1 (0.9) 0 (0.0
Continued
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Cancer types covered
No (N) (all apps, 
n=151 n (%)
Unique to Apple
n=47,
N (%)
Unique to 
Google n=38
N (%)
Price to download (£ Sterling)
  Free 140 (92.7) 46 (97.9) 34 (89.5)
  <£9.49 Google Play/<£12.99 App store 9 (6.0) 1 (2.1) 2 (5.3)
  >£12.99 2 (1.3) 0 2 (5.3)
Table 1 Continued
Table 2 Themes present within APP marketing statements with example quotations
Theme Example app (name in Italics) with quotations from on-line app store
Fighting for life Twist out cancer: ‘(get to) know other cancer survivors who fought with odds and kicked cancer in the butt!’
‘Whip cancer provides people with the power to instantly and accurately picture the cancer cells they want 
to expel from their bodies… Whip Cancer is a powerful tool to help you become relaxed and thus feel 
empowered while battling your cancer.’
Navigating a 
journey
Breast Cancer healthline: ‘You’re not on this journey alone. Are you facing a diagnosis? Already in 
treatment? Remission? We’ll connect you with people just like you, at the same stage in the journey’.
‘The BigC-Connect platform has been designed to help survivors of cancer on their journey to survival.’
Being empowered 
to take control
‘Hearing that you have been diagnosed with breast cancer can turn your world upside down. The OWise 
breast cancer app can help you regain control during the chaotic times of illness and treatments’
‘Blood Cancer Storylines is filled with great tools to help you take control of your health.’
support and Pratheeksha) allowed registered patients to 
view or change appointments.
Nine apps listed cancer clinical trials that may be rele-
vant to individuals living with cancer, and one (Belong 
Life) offered a clinical trials matching service based on 
parameters entered by the user. Two apps supported 
survivorship care plans (SCPs). My Care Plan suggested 
that users should input data to create their own SCP, and 
then complete it with their oncologist. The Survivor Care 
app allowed registered patients with testicular cancer to 
use the app to read a QR code (quick response code or 
matrix bar code), generated by their specialist, which 
gave them access to a personalised care plan.
Interacting with others
Twenty five apps (16.6%) offered access to an on-line 
community (social network) of other individuals with 
cancer, promoting these networks as sources of support 
and information. Four of these (Boobytrapp, Breast Cancer 
Health, Breast Cancer Social and Cnected) advertised a 
matching service in which users could be matched with 
other users or groups based on characteristics such as 
cancer type, stage, treatments and interests.
Apps also offered interaction with healthcare profes-
sionals: three apps ( Belong. life, Breast Friends app and 
Cancer Connect) listed the ability to message or ask ques-
tions of professionals who were linked to the app plat-
form. Four apps (Medocity’s iCancer Health, MD Andersen 
Mobile, MyMSK and Pratheeksha) allowed users to login 
and send messages to their linked care team.
Enacting management strategies and adjusting to life with or 
beyond cancer
Specific aspects of self-management supported by apps 
include symptom tracking and monitoring; setting alarms 
or reminders to take medications regularly, tracking and 
adjusting diet and physical activity levels, using psycholog-
ical and complementary approaches, and knowing when 
to seek medical attention for chemotherapy side effects.
Twenty-nine apps (19.2%) allowed users to track their 
symptoms: mainly fatigue, pain, mood changes, nausea 
and sleep problems. Some suggested monitoring physical 
or physiological parameters, including pulse, blood pres-
sure and weight, and some allowed customisation, letting 
the user decide which symptoms/parameters to monitor. 
The recommended frequency of self-monitoring varied, 
with some promoting weekly input, some apps suggesting 
on-demand tracking when symptoms were experienced, 
and others not specifying particular intervals for self-mon-
itoring. Apps used a number of rating scales, including 
touch-screen sliders, and faces rating scales. The data 
were used to provide graphs and output reports (see 
‘feedback’ below).
Fifteen apps (9.9%) gave advice about diet and/or exer-
cise after a cancer diagnosis, with five allowing users to 
track their exercise or dietary activities. Four apps offered 
integration with wearable fitness trackers.
Complementary and alternative therapies were a 
prominent component of 12 apps (7.9%), which gave 
instructions on relaxation techniques, provided ‘healing’ 
music playlists, and taught guided imagery, visualisation, 
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Table 3 Advertised app functions that support cancer survivorship activities
Survivorship activity App feature
No (%) apps which 
advertised this 
feature
Imparting information 
about cancer
Delivers information about the nature of cancer, cancer terminology, treatment 
approaches and services. Apps present information as text, news feeds/
updates, videos and question/answer formats.
81 (53.6)
Gives dietary and/or exercise advice, targeting individuals living with and 
beyond cancer.
15 (9.9)
Planning and organising 
cancer care
Upload and store personal records, for example, diaries/journals, results. 25 (16.6)
Keep a list of medications±their scheduling. 20 (13.3)
Share uploaded personal records with others. 8 (5.3)
Keep a calendar of appointments. 12 (8.0)
Login to view or change clinical appointments. 4 (2.7)
Login to remotely access clinical records or results. 3 (2.0)
Create or view survivorship care plan. 2 (1.3)
Lists available clinical trials. 9 (6.0)
Clinical trials matching. 1 (0.7)
Interacting with others Access to an on-line cancer community or social network (four offered a 
matching service).
25 (16.6)
List of local (geographically limited) sources of peer support. 11 (7.3)
Message a linked healthcare professional. 4 (2.7)
Ask a professional within an on-line community. 3 (2.0)
Enacting management 
strategies and adjusting
Track and record-specific symptoms or physiological parameters. 29 (19.2)
Provides symptom management tips and advice. 5 (3.3)
Set alarms as reminders to take medication. 14 (9.3)
Track fitness or diet (four apps offered integration with wearable fitness 
trackers).
5 (3.2)
Delivers instructions on complementary and/or alternative therapies. 12 (7.9)
Delivers psychological therapies. 3 (2.0)
Offers spiritual support, for example, bible verses, prayers. 2 (1.4)
Getting feedback about 
cancer management
Generates graphical summaries of self-monitoring data for personal reflection 
and sharing with others (particularly clinicians).
21 (13.9)
Generates or supports creation of question prompt lists (intended to be used 
during medical encounters).
13 (8.6)
Allows video or audio recording of medical consultations. 4 (2.7)
meditation, Qigong and yoga. The MeTime app, devel-
oped by University of Michigan, taught acupressure to 
manage fatigue in breast cancer survivors, and quoted 
evidence supporting its use from a randomised controlled 
trial.29 Three apps (Emory Awake, UNTIRE and Bubble VR) 
delivered programmes of psychological therapy to cancer 
survivors; for example, Bubble VR delivered cognitive 
behavioural therapy, guided imagery, meditation and 
mindfulness-based stress reduction within Virtual Reality. 
The app was linked to a focus group research study, and 
registered participants could use a PIN code to interact 
with it.
Three apps (CanAdvice+, Cancer Emergency Response 
Tool and For Cancer Care) specifically targeted people 
on chemotherapy, and sought to help users judge 
when to seek medical attention for side effects or 
problems experienced during chemotherapy. CanAd-
vice+ and Cancer Emergency Response Tool were linked to 
UK cancer centres and used the UK Oncology Nurses 
Society triage tool,30 whereas For Cancer Care offered 
generic tips and advice to manage chemotherapy side 
effects.
Some apps dealt with changes in body image after 
cancer and psychological adjustment to physical 
changes. Inkspiration app allowed users to ‘try on’ 
mastectomy tattoos, super-imposing tattoos onto 
photo uploads. The Breast Cancer Care app (BECCA) 
offered beauty tips alongside other information about 
breast cancer.
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Getting feedback about cancer management
Twenty-one apps (13.9%) allowed users who had tracked 
symptoms to generate graphical summaries of their 
self-monitoring data for personal reflection (usually line 
graphs showing, for example, pain levels plotted against 
date/time), and to generate output reports from the 
data, usually by email. A central premise was that users 
would learn about patterns within their symptoms, and 
that sending their symptom reports to professionals could 
result in action by the professional to help with symptom 
management.
Apps also attempted to influence clinical encounters 
between users and their clinicians by allowing them to 
generate (sometimes from templates or lists) or store 
questions that they would like to ask at the next medical 
encounter (n=13, 8.6%). Four apps (Focus on Lymphoma, 
My Cancer Coach, OWise Breast Cancer and Pocket Cancer Care 
Guide—National Coalition for Cancer Survivorship) allowed 
users to video or audio record their medical consultations.
Clinical and/or scientific basis for App content and Apps as 
commercial opportunities
Fifty-one out of 151 apps (33.8%) cited clinical or scien-
tific/clinical research team input into the development 
of the app within the on-line description. Most of these 
apps were developed by recognisable institutions, such 
as universities, clinics or charities. However, one app, 
Don’t Die 2 retailing at £299.99 on Google Play, had 
limited information about content, and stated: ‘Contains 
new cancer approach not previously available to cancer 
victims. All results obtained after a rigorous 12-year study 
and when applied to active cancer patients show dramatic 
results increasing survival results.’ The app was developed 
by a family cancer foundation (MiSong Foundation), and 
screenshots showed an enquiry form which users could 
fill in for further information. Links to the developer 
website were inactive.
We found a number of apps offering purchasable 
products to cancer survivors and apps that made claims 
about offering a potential cancer cure. Best Prostate Cancer 
Treatment opened its description by stating: ‘Court Docu-
mented Proof That The Cure For Prostate Cancer & 
Colon Cancer is real’. Screenshots from the app were 
captioned with ‘PROSTATE CANCER Cure for Cancer 
Now Available’, and the app offered treatments based 
on whole-leaf Aloe Vera. One screenshot showed an 
‘Advanced Package’ with products available for US750. 
The app description marketed the product as follows: 
‘The advanced package provides specific elements to 
expedite the healing process. This package revitalises and 
engages intercellular advancement and ease in detoxi-
fication’. Cancel Cancer mentioned links between body 
acidity and cancer, and screenshots from the app showed 
order forms, products for sale, and videos about Kangen 
water, an alkaline water.
Three apps contained the word ‘cure’ in their title. 
Cancer Cure (retailing on Google for £28.99) offered 
‘300 alternate healing ideas’ and was recommended for 
‘anyone who is struggling for cancer survival’. Cancer 
Curing Foods (free to download) had been downloaded 
more than 10 000 times on Google Play and offered ‘top 
10 fruits, vegetables and foods that can cure cancer’. 
Various Cancer Cures, offered free via Google Play, listed 
information about surgery, chemotherapy and radio-
therapy as treatment options for cancer.
Cancer Wellness invited users to complete a weekly 
cancer survey, with links to a private clinic in the Pacific 
Islands (http:// cancerwellnessclinic. com/ our- treatment- 
program/) that offered alternative cancer treatments 
and supplements. In Ways to Fight Off Cancer, available 
on Google Play, the on-line description had statements 
that included ‘broccoli cures cancer’ and ‘tomato cures 
cancer’… ‘So What Are you Waiting For !?! Download 
the 'Ways Fight Off Cancer' Now!’ Other potentially exag-
gerated claims were found in apps promoting comple-
mentary therapies and visualisation; for example, Cancer 
Fighting App stated (sic.) ‘After working on visualisation 
for few weeks, the cancer tumour had shrunk to small 
its size and its continuous become smaller and smaller. 
Imagination and visualisation for creating radiant, life-
long health and happiness.’
DISCuSSIOn
Main findings
We reviewed 151 apps targeting individuals living with 
and or beyond cancer, available for download via on-line 
stores. The apps are often marketed in terms of fighting 
cancer, taking a journey and taking control. Apps are 
heterogeneous in terms of aims and scope, but typical 
content includes informational resources, diary func-
tions, access to on-line social networks/communities 
and symptom-tracking capabilities linked to graphical 
outputs.
App owners came from a range of backgrounds (eg, 
non-profit organisations, academic institutions and 
healthcare providers), but most publicly available apps 
had been developed by commercial or private organ-
isations. We were unable to discern the nature of the 
developer in 16 apps, despite visiting linked websites. We 
also found some apps that seemed to make exaggerated 
claims, for example, about foods that cure cancer, visuali-
sation regimes that shrink tumours (see examples above), 
and apps that marketed or sold products with question-
able efficacy (eg, Kangen water or Aloe Vera extract).
Comparison with existing literature and implications for 
practice, policy and research
Violence and journey metaphors are known to be widely 
used in the context of cancer and cancer fundraising 
campaigns, and have sparked debate.31 Both violence and 
journey metaphors can be perceived in both positive, and 
in disempowering ways. We found these metaphors to be 
prominent in on-line app marketing.
Apps cover some of the areas that are recommended in 
clinical guidelines for cancer survivorship care,32 such as 
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box 1 Four D’s to discuss with patients if they are 
considering using a health app
Does something useful—does it solve a problem you are having?
Design—are there screenshots that summarise the content and give 
you an impression of how you would use the app?
Developer—do you recognise a credible organisation/source behind 
the app, and do links to the developer website work?
Data—does the app ask you for personal information that you would 
prefer not to be shared with others or provide a transparent description 
of how data will be used and shared?
information provision; making lifestyle changes (particu-
larly diet and exercise), dealing with physical and psycho-
social effects of cancer and its treatment, and providing 
SCPs. The potential usefulness of reputable apps may be 
undermined by the fact that they appear in stores along-
side those that are potentially exploitative.
Guidelines and regulatory procedures for health apps 
have been introduced in the UK33 34 and USA,35 but these 
mainly apply to apps classed as medical devices (used to 
diagnose, support diagnosis or clinical decision-making 
or make calculations to determine diagnosis or treat-
ment), which are considered to carry the highest risks. 
Apps that provide education, monitor health or well-
being, and store or transmit data without change are not 
subject to the same regulatory procedures.34 These types 
of apps can be developed quickly by anyone who wishes 
to,36 without specific regulatory requirements.
There is increasing recognition that lack of public 
trust is a major barrier to the successful utilisation of 
data and technology to improve patient outcomes.37 In a 
recent review, Wyatt discussed problems with health apps, 
including privacy issues, poor quality content and variable 
accuracy, for example, in diagnosing melanoma.38 In our 
review, most apps were free, and it was beyond the scope 
of this review to determine how apps attracted revenue. 
Potential sources include advertising, in-app purchases 
and data ‘harvesting’. There is increasing evidence that 
sharing of user data is routine in medical apps39 and that 
data harvesting for targeted advertising is an important 
source of revenue for many app developers.38
Questions remain about the clinical role of cancer 
apps, how they affect formal medical care and influence 
clinical outcomes. Some of the apps we reviewed helped 
users to generate lists of questions that could be taken to 
appointments or facilitated video or audio recording of 
consultations. Formal trials of this type of approach have 
shown promise in the oncology setting, with respect to 
improving patients’ information needs, their satisfaction 
with patient–professional communication and recall of 
information.40–42 Whether these findings can be extrapo-
lated to specific apps is unclear.
Many of the apps we reviewed attempted to influence 
medical care by suggesting that self-monitoring reports 
be shared with clinicians. Patient-reported outcome 
monitoring has been shown to improve patient satisfac-
tion with care in the oncology setting, and to increase 
the number of patient outcomes that are discussed 
during consultations.26 27 However, any effects are likely 
to be contingent on how the data are used during clinical 
encounters and what data are collected.43 Scientific trials 
tend to use validated questionnaires, as opposed to the, 
often generic, tools present within apps.
There seems to be a widely held assumption in 
symptom management apps that providing patients 
with simple graphical summaries of their self-reported 
symptom data will afford insights that could improve 
symptom management. Conversely, there is a danger 
that apps could increase the work and burden of cancer 
survivorship activities without resultant benefits to the 
user. We noted close parallels between categories of app 
content (table 3), and models of treatment burden in 
other chronic conditions.29–31
The app market is a potentially challenging environ-
ment for patients and clinicians to navigate in terms 
of judging app quality, effectiveness, clinical utility and 
data privacy. It may be that app stores themselves should 
be asked to take more responsibility for the content of 
the apps they offer. Several high-profile scandals, for 
example, Cambridge Analytica allegedly using Facebook 
data to influence election results,44 and suicides poten-
tially linked to social media use,45 have led to increased 
public scrutiny surrounding the social responsibilities of 
technology providers. With respect to app stores, existing 
legislation, such as trading standards regulations that 
prevent false or misleading advertising, and General 
Data Protection Regulation might be enforced to protect 
consumers. The National Health Service has also started 
a library of approved apps that have been screened 
against quality criteria.46 Three of the apps reviewed 
here, BECCA, OWISE breast cancer and Untire: Beating cancer 
fatigue, appear in the library.
While app stores continue to offer low-quality and 
potentially exploitative apps, we propose a rudimentary 
checklist (box 1), the ‘Four D’s’, which might be used by 
patients before downloading a health app. The checklist 
was derived pragmatically, based on our experiences of 
conducting this review, and on the existing literature/
guidelines discussed above.33 35 38 39
Intuitively, we considered a fifth ‘D’—Downloads, in 
which the number of downloads and positive/detailed 
consumer reviews might serve as an indicator of quality 
and trustworthiness. Box 1 Apps by reputable organisa-
tions tended to be highly downloaded, but we also found 
highly downloaded apps which seemed to be of low 
quality for example, Cancer Curing Foods, offering ‘top 
10 fruits, vegetables and foods that can cure cancer’ had 
been downloaded over 10 000 times. We also considered 
that some app reviews could be false or purposefully 
misleading. The association between number of down-
loads and objective measures of quality deserve further 
attention.
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Strengths and limitations
The app market is changing rapidly—more apps are 
being added to app stores every day, and it is also possible 
for developers to delete apps from on-line stores. We 
have presented a snapshot of what was available between 
September 2018 and May 2019. The main limitation 
of this review is that we did not download and interact 
with individual apps. To have done so would have added 
considerable time to the review process (which was 
time-sensitive, given the changing nature of the market), 
and would have also involved buying several apps that 
looked to have limited content (eg, ‘Don’t die 2’ retailed at 
£299.99). Our content analysis is based on what was stated 
in on-line descriptions, and may underestimate content 
contained within the apps. We did not register a review 
protocol, which is a relatively new requirement in updated 
Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses guidelines for scoping reviews, which were 
published after we started this review.47
App stores are commercial entities and are not search-
able in the same way as databases of published medical 
literature. We fully expect that other relevant apps exist 
which have not been identified by our searches. Further-
more, it is not possible to save or export searches. Apps 
are displayed in an order that is determined by on-line 
stores, and, to the best of our knowledge, the exact sort 
algorithms used by stores are not in the public domain. 
This makes searches difficult to accurately reproduce, 
and made it difficult to involve two authors in all stages of 
the app selection process. Nevertheless, where possible, 
we have adopted principles of systematic reviewing. We 
are confident that we have identified apps in a systematic 
and unbiased way and have characterised a large spec-
trum of currently available apps.
COnCluSIOnS
Apps exist that cover a large spectrum of cancer survi-
vorship activities: key components are information provi-
sion, storing personal summaries and self-monitoring. 
The effects of such apps on clinical consultations, patient 
work/burden and clinical outcomes merit further atten-
tion. Most apps are developed by commercial organisa-
tions and promises of empowerment in the ‘fight’ against 
cancer are tempered by the potential for exaggerated 
claims and exploitation.
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